Monica Mann, Ph.D. joined Parker Highlander after completing a Biomedical Science graduate program at the University of Texas Health Science Center in the area of cancer biology and a post-doctoral fellowship at MD Anderson Cancer Center. Prior to her graduate studies, Monica obtained a B.S. in Biochemistry at Case Western Reserve University. During her graduate program, Monica worked in the area of understanding the mechanism of resistance to hormonal therapy in breast cancer and developing methods to overcome this resistance. Since joining Parker Highlander, Monica has focused on patentability searches, freedom-to-operate analyses, and biotechnology patent prosecution.
Monica received her Ph.D. at the University of Texas Health Science Center at San Antonio in Biomedical Sciences, particularly focusing on Cancer Biology. Her research focused on epigenetics in breast cancer and identifying novel targets for overcoming resistance to hormonal therapy. Since joining Parker Highlander, Monica has gained experience in drafting patent applications and performing patentability analyses.